DFE Pharma is an international company specialized in the production of first-class excipients. They develop, produce and market excipients for oral dosage forms of solid drugs and for formulations for dry powder inhalation. With global sales offices in Germany, the USA, Singapore, Japan, India, China and Brazil DFE Pharma generates sales in more than 100 countries worldwide. For more information please refer to this link.

The DDIC was founded in 2017 by the companies Bayer AG, LB Bohle GmbH, Merck KGaA (all Germany) and UCB S.A (Belgium), together with the university partners TU Dortmund and HHU Düsseldorf. INVITE GmbH is leading the consortium. The DDIC fosters international, multi-disciplinary networks in the research area of drug delivery and manufacturing, it promotes pharmaceutical science in close collaboration with academia and pharmaceutical industry along the value chain.